Australia's most trusted
source of pharma news
Friday, 31 October 2025
Friday, 31 October 2025
Subscribe
Login
Tough ride for AZ's Aussie CFO
Driven by the loss of his mum to metastatic breast cancer, finance boss Michael Lauritzen tackled a gruelling 180km ride for charity this week and although tough, it paled compared to the challenges facing patients every day.
CEO out after damning sales probe
So-called "channel-stuffing" scandal sends boss packing plus the other most popular stories this week
TODAY Your Week in 5 Minutes
Shake-up in top PBS earners list
With biosimilar competition taking out two high fliers, which drugs have taken their place in the top ten?
TODAY
Who made the MA Board cut?
Two country leaders join the industry organisation Board as Directors, at a pivotal time for pharma and HTA reform
30 October
AbbVie shakes up local leadership
A couple of high level changes at AbbVie see some experienced leaders moving cities to take up new leadership roles
29 October
Nov PBS listing doubles market
Company wins expansion which opens the doors to subsidised access to treatment for 70,000 Australians
29 October
CEO quits over 'improper' selling
This Big Pharma boss has walked away with no severance or equity related benefits after an internal company investigation
28 October
Latest Jobs
Customer Service RepresentativeTechnical Service & Warehouse CoordinatorService AdministratorClinical Affairs LeadQC MicrobiologistKey Account ManagerPharmacovigilance AssociateQuality assurance associate27 more...
Pharma in Focus Jobs
Marketing & Communications (4)
- Brand Manager - Melbourne
- Senior Product Manager - Sydney
- Associate Brand Manager - Sydney
- Associate Brand Manager - Sydney
Sales & Customer Relations (13)
- Customer Service Representative - Macquarie Park
- Key Account Manager - Sydney
- Customer Service Representative - Macquarie Park
- GP Sales Representative - NSW Mid North Coast - AstraZeneca - NSW
- GP Sales Representative - Cronulla - AstraZeneca - Cronulla, NSW
- Key Account Manager - Melbourne
- GP Sales Representative - Brisbane North - Flexible 3 Days - AstraZeneca - Brisbane
- GP Sales Representative - Sydney
- Customer Service Representative - St Leonards
- Key Account Manager - Renal Metabolic - Adelaide - AstraZeneca - Adelaide, SA
- GP Sales Representative - Adelaide South - AstraZeneca - Adelaide, SA
- GP Sales Representative - Bundaberg, QLD - AstraZeneca - Bundaber, QLD
- Territory Manager - Melbourne
Clinical & Medical, R&D (7)
- Clinical Affairs Lead - Sydney
- QC Microbiologist - Broadmeadows
- QC Scientist - 40120 - Broadmeadows
- Medical Director - Sydney
- QCE Scientist Instrumentation (GDIP) - Broadmeadows
- Medical Advisor - Sydney
- Medical Advisor - Sydney
Regulatory, Pharmacovigilance & QA (3)
- Pharmacovigilance Associate - Sydney
- Quality assurance associate - Sydney
- Regulatory Affairs Associate - Sydney
Executive Roles (2)
- Senior Manager - Cell Therapy - Australia - AstraZeneca - Sydney or Melbourne
- Medical Director - Sydney
Other (8)
- Technical Service & Warehouse Coordinator - Alexandria
- Service Administrator - Belrose
- Warehouse & Logistics Officer - Macquarie Park
- Financial Reporting Manager - Macquarie Park
- Financial Analyst - Melbourne
- Finance Business Partner - Surry Hills
- Logistics Specialist - Macquarie Park
- Senior Recruitment Consultant - Victoria
CAR-T therapy gets third tick
MSAC approved a new indication but demanded a price cut, denying there was enough evidence to support claims it was a cure
TODAY
$1.6B disease few Aussies know
New report backed by Sanofi unpacks the human and economic burden of COPD in Australia and the figures are disturbing
TODAY
CSL conquers new Kingdom
Signs landmark deal which will see it expand to the Middle East as part of a push into new markets with a high flu burden
30 October
Pharmac wants to say a clear 'No'
NZ funding body has opened consultation on changing the way medicine funding applications are managed, to kick some off the list
30 October
J&J sues to protect $74M franchise
Generic companies are making moves three years before exclusivity ends, and J&J isn't happy
30 October
Hot market on the slide
Big drugs on the verge of exclusivity losses but the next generation of treatments are ready to fill the gap
30 October
Milestone event for pharma women
An Australian branch of this professional organisation has seen membership boom as it gears up for a 1st anniversary celebration
29 October
Company blasts AMA 'mistake'
Protecting patients or misinforming them? Debate heats up in controversial space currently the subject of a TGA review
29 October
Aussies "frustrated" by PBS failings
Pfizer survey lifts lid on growing public unrest over medicines access as fewer innovative drugs make it to Australia
29 October
Slowdown looms for major market
A booming drug class will soon see its growth rate halve as competition begins to bite, according to analysts, but it's not all bad news
28 October
New hires, exits and a retirement
The latest round of employment moves across the Australian industry is a mixed bag with arrivals, departures and a goodbye
28 October
CSL's Seqirus spin-off on pause
Drop in US vaccination rates delays the separation of Seqirus while adjusted revenue estimates, lead to a share price plummet
28 October
Novartis seals $18B mega buyout
Deal sees the pharma take control of three potential first-in-class, late-stage clinical assets targeting neuromuscular diseases
28 October
Workers too worried to switch off
A year after Australia's Right to Disconnect laws came into force, experts warn that for many, switching off feels like a career risk
27 October